资讯
Schrödinger, Inc. (Nasdaq: SDGR) today announced the grant of inducement equity awards to the company’s newly appointed EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...
The Nationwide League One (NLO) has warned clubs against luring of players from non-professional teams. The NLO stated that ...
In Kousisis v. United States, 605 U.S. ___ (2025), the Supreme Court resolved a Circuit split addressing the scope of the federal wire fraud ...
The equity awards were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception ...
If a defendant uses material misrepresentations to induce a party to enter a contract, but does not economically harm the induced party, has ...
The 2023 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of IDEAYA, or following a bona fide period of non-employment, as an ...
4 天
Independent Newspaper Nigeria on MSNAlleged Financial Inducement: Lawyer Petitions IGP, Demands Probe Of Police CommissionerAn Abuja constitutional lawyer and human rights activist, Barr. Victor Giwa, has written a petition to the Inspector- General of Police, Mr Kayode Egbetokun, demanding the investigation of the ...
Notwithstanding Ciminelli, the U.S. Court of Appeals for the Third Circuit upheld the conviction, ruling that Kousisis had engaged in "fraud in the inducement," fraudulently inducing PDOT to pay ...
The Inducement Grants have been granted pursuant to the Company’s 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals ...
WALTHAM, Mass., March 10, 2025--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and ...
Iovance Biotherapeutics, Inc. announced the grant of inducement stock options for 297,600 shares of common stock to fifty new non-executive employees as part of its Amended and Restated 2021 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果